79 related articles for article (PubMed ID: 21778310)
21. CT-guided brachytherapy (CTGB) versus interstitial laser ablation (ILT) of colorectal liver metastases: an intraindividual matched-pair analysis.
Pech M; Wieners G; Kryza R; Dudeck O; Seidensticker M; Mohnike K; Redlich U; Rühl R; Wust P; Gademann G; Ricke J
Strahlenther Onkol; 2008 Jun; 184(6):302-6. PubMed ID: 18535805
[TBL] [Abstract][Full Text] [Related]
22. [Clinical value of CT-guided (125)I brachytherapy for retroperitoneal metastatic lymph node from PHC].
Gao F; Gu YK; Huang JH; Zhang FJ; Wu PH
Zhonghua Yi Xue Za Zhi; 2013 Jul; 93(27):2155-7. PubMed ID: 24284250
[TBL] [Abstract][Full Text] [Related]
23. Interstitial high-dose-rate-brachytherapy in advanced esthesioneuroblastoma.
Tselis N; Heyd R; Baghi M; Zamboglou N
Laryngoscope; 2008 Nov; 118(11):2006-10. PubMed ID: 18641524
[TBL] [Abstract][Full Text] [Related]
24. Hepatic yttrium-90 radioembolization of chemotherapy-refractory colorectal cancer liver metastases.
Jakobs TF; Hoffmann RT; Dehm K; Trumm C; Stemmler HJ; Tatsch K; La Fougere C; Murthy R; Helmberger TK; Reiser MF
J Vasc Interv Radiol; 2008 Aug; 19(8):1187-95. PubMed ID: 18656012
[TBL] [Abstract][Full Text] [Related]
25. Hepatocellular carcinoma: computed-tomography-guided high-dose-rate brachytherapy (CT-HDRBT) ablation of large (5-7 cm) and very large (>7 cm) tumours.
Collettini F; Schnapauff D; Poellinger A; Denecke T; Schott E; Berg T; Wust P; Hamm B; Gebauer B
Eur Radiol; 2012 May; 22(5):1101-9. PubMed ID: 22173693
[TBL] [Abstract][Full Text] [Related]
26. Detection of liver metastases from endocrine tumors: a prospective comparison of somatostatin receptor scintigraphy, computed tomography, and magnetic resonance imaging.
Dromain C; de Baere T; Lumbroso J; Caillet H; Laplanche A; Boige V; Ducreux M; Duvillard P; Elias D; Schlumberger M; Sigal R; Baudin E
J Clin Oncol; 2005 Jan; 23(1):70-8. PubMed ID: 15625361
[TBL] [Abstract][Full Text] [Related]
27. Complications of Computed Tomography-Guided High-Dose-Rate Brachytherapy (CT-HDRBT) and Risk Factors: Results from More than 10 Years of Experience.
Böning G; Büttner L; Jonczyk M; Lüdemann WM; Denecke T; Schnapauff D; Wieners G; Wust P; Gebauer B
Cardiovasc Intervent Radiol; 2020 Feb; 43(2):284-294. PubMed ID: 31797103
[TBL] [Abstract][Full Text] [Related]
28. Pilot study in the treatment of endometrial carcinoma with 3D image-based high-dose-rate brachytherapy using modified Heyman packing: clinical experience and dose-volume histogram analysis.
Weitmann HD; Pötter R; Waldhäusl C; Nechvile E; Kirisits C; Knocke TH
Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):468-78. PubMed ID: 15890589
[TBL] [Abstract][Full Text] [Related]
29. Prospective study of contrast-enhanced computed tomography, computed tomography during arterioportography, and magnetic resonance imaging for staging colorectal liver metastases for liver resection.
Bhattacharjya S; Bhattacharjya T; Baber S; Tibballs JM; Watkinson AF; Davidson BR
Br J Surg; 2004 Oct; 91(10):1361-9. PubMed ID: 15376205
[TBL] [Abstract][Full Text] [Related]
30. Comparison of gadoxetic acid-enhanced MR imaging versus four-phase multi-detector row computed tomography in assessing tumor regression after radiofrequency ablation in subjects with hepatocellular carcinomas.
Yoon JH; Lee EJ; Cha SS; Han SS; Choi SJ; Juhn JR; Kim MH; Lee YJ; Park SJ
J Vasc Interv Radiol; 2010 Mar; 21(3):348-56. PubMed ID: 20116285
[TBL] [Abstract][Full Text] [Related]
31. Proposed guidelines for image-based intracavitary brachytherapy for cervical carcinoma: report from Image-Guided Brachytherapy Working Group.
Nag S; Cardenes H; Chang S; Das IJ; Erickson B; Ibbott GS; Lowenstein J; Roll J; Thomadsen B; Varia M;
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1160-72. PubMed ID: 15519788
[TBL] [Abstract][Full Text] [Related]
32. 90Y microsphere (TheraSphere) treatment for unresectable colorectal cancer metastases of the liver: response to treatment at targeted doses of 135-150 Gy as measured by [18F]fluorodeoxyglucose positron emission tomography and computed tomographic imaging.
Lewandowski RJ; Thurston KG; Goin JE; Wong CY; Gates VL; Van Buskirk M; Geschwind JF; Salem R
J Vasc Interv Radiol; 2005 Dec; 16(12):1641-51. PubMed ID: 16371530
[TBL] [Abstract][Full Text] [Related]
33. [Interventional therapy for liver metastases].
Ricke J
Z Gastroenterol; 2004 Nov; 42(11):1321-8. PubMed ID: 15558444
[TBL] [Abstract][Full Text] [Related]
34. Gadoxetic acid-enhanced MRI versus multiphase multidetector row computed tomography for evaluating the viable tumor of hepatocellular carcinomas treated with image-guided tumor therapy.
Hwang J; Kim SH; Kim YS; Lee MW; Woo JY; Lee WJ; Lim HK
J Magn Reson Imaging; 2010 Sep; 32(3):629-38. PubMed ID: 20815061
[TBL] [Abstract][Full Text] [Related]
35. Survival impact of surgical cytoreduction in stage IV epithelial ovarian cancer.
Bristow RE; Montz FJ; Lagasse LD; Leuchter RS; Karlan BY
Gynecol Oncol; 1999 Mar; 72(3):278-87. PubMed ID: 10053096
[TBL] [Abstract][Full Text] [Related]
36. Brachytherapy of liver metastases.
Denecke T; Lopez Hänninen E
Recent Results Cancer Res; 2008; 177():95-104. PubMed ID: 18084951
[TBL] [Abstract][Full Text] [Related]
37. Percutaneous ablation of lymph node metastases using CT-guided high-dose-rate brachytherapy.
Collettini F; Schippers AC; Schnapauff D; Denecke T; Hamm B; Riess H; Wust P; Gebauer B
Br J Radiol; 2013 Jul; 86(1027):20130088. PubMed ID: 23659925
[TBL] [Abstract][Full Text] [Related]
38. CT-guided high-dose-rate brachytherapy of liver tumours does not impair hepatic function and shows high overall safety and favourable survival rates.
Brinkhaus G; Lock JF; Malinowski M; Denecke T; Neuhaus P; Hamm B; Gebauer B; Stockmann M
Ann Surg Oncol; 2014 Dec; 21(13):4284-92. PubMed ID: 24934583
[TBL] [Abstract][Full Text] [Related]
39. [Selective internal radiotherapy for advanced liver tumors and metastases].
Hoffmann RT; Jakobs TF; Tatsch K; Reiser MF
Dtsch Med Wochenschr; 2008 Oct; 133(41):2099-102. PubMed ID: 18814106
[No Abstract] [Full Text] [Related]
40. Perihepatic metastases from ovarian cancer: sensitivity and specificity of CT for the detection of metastases with and those without liver parenchymal invasion.
Akin O; Sala E; Moskowitz CS; Ishill N; Soslow RA; Chi DS; Hricak H
Radiology; 2008 Aug; 248(2):511-7. PubMed ID: 18519739
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
